Gilead Asset Team Leader - Oncology

Gilead Sciences(1 month ago)

HybridFull TimeExecutive$302,005 - $390,830Research and Development

About this role

The Strategic Asset Leader at Gilead defines and oversees development strategy for multiple biologic-modality programs (typically 4–5 molecules), guiding assets from early clinical phases through proof-of-concept. The role operates at the intersection of scientific, medical, and commercial strategy to shape the early portfolio and ensure program viability. It is a senior, enterprise-facing position contributing to portfolio and therapeutic-area planning.

View Original Listing

Required Skills

Strategic Leadership
Asset Strategy
Portfolio Management
Cross-Functional Collaboration
Drug Development
Translational Research
Risk Mitigation
Stakeholder Engagement
Clinical Development
Decision Making

+2 more

Qualifications

BS Degree
PhD
MD
MBA

About Gilead Sciences

gilead.com

Gilead Sciences is a biopharmaceutical company dedicated to transforming patient care by advancing therapeutics in areas like HIV, liver disease, cancer, and inflammation. With a strong commitment to innovation, Gilead leads in the research and development of new medicines, aiming to make the world a healthier place. Their portfolio includes breakthrough therapies and ongoing advancements across multiple therapeutic areas, supported by a robust pipeline of clinical trials. Gilead is recognized for its contributions to public health and its efforts to improve access to vital medications.

View more jobs at Gilead Sciences →